SG11201403447VA - Use of hla-b*1301 allele - Google Patents

Use of hla-b*1301 allele

Info

Publication number
SG11201403447VA
SG11201403447VA SG11201403447VA SG11201403447VA SG11201403447VA SG 11201403447V A SG11201403447V A SG 11201403447VA SG 11201403447V A SG11201403447V A SG 11201403447VA SG 11201403447V A SG11201403447V A SG 11201403447VA SG 11201403447V A SG11201403447V A SG 11201403447VA
Authority
SG
Singapore
Prior art keywords
hla
allele
Prior art date
Application number
SG11201403447VA
Inventor
Furen Zhang
Shumin Chen
Hong Liu
Original Assignee
Shandong Provincial Inst Of Dermatology And Venereology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Provincial Inst Of Dermatology And Venereology filed Critical Shandong Provincial Inst Of Dermatology And Venereology
Publication of SG11201403447VA publication Critical patent/SG11201403447VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201403447VA 2012-10-23 2013-06-18 Use of hla-b*1301 allele SG11201403447VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2012104071492A CN102925567B (en) 2012-10-23 2012-10-23 Use of HLA-B*1301 alleles
PCT/CN2013/000714 WO2014063433A1 (en) 2012-10-23 2013-06-18 Use of hla-b*1301 allele

Publications (1)

Publication Number Publication Date
SG11201403447VA true SG11201403447VA (en) 2015-06-29

Family

ID=47640490

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403447VA SG11201403447VA (en) 2012-10-23 2013-06-18 Use of hla-b*1301 allele

Country Status (8)

Country Link
US (1) US9567636B2 (en)
EP (1) EP2787085B1 (en)
JP (1) JP6188810B2 (en)
KR (1) KR102154816B1 (en)
CN (1) CN102925567B (en)
PH (1) PH12014501775B1 (en)
SG (1) SG11201403447VA (en)
WO (1) WO2014063433A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102925567B (en) 2012-10-23 2013-12-11 山东省皮肤病性病防治研究所 Use of HLA-B*1301 alleles
CN104818316B (en) * 2013-11-28 2018-09-21 复旦大学 Human leukocyte antigen gene detecting kit for dermal drug adverse reaction caused by screening salicylazosulfapyridine
CN110100001B (en) * 2016-10-27 2024-03-01 长庚医疗财团法人林口长庚纪念医院 Method for evaluating risk of drug anaphylactic reaction caused by sulfamethoxazole and/or trimethoprim
CN107447024B (en) * 2017-09-11 2019-12-24 长沙都正医学检验有限责任公司 Application of HLA-B allele in preparation of detection reagent for predicting risk of liver injury caused by plant polygonum multiflorum and components thereof
KR20230045092A (en) * 2020-08-18 2023-04-04 창 궁 메모리얼 하스피털, 린커우 Method and kit for detecting drug hypersensitivity reaction induced by sulfonamide derivative antiepileptic drugs, and use of the kit
CN112143787B (en) * 2020-09-09 2022-09-06 复旦大学 Novel use of HLA-B13 gene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002539450A (en) * 1999-03-15 2002-11-19 レイランド−ジョーンズ，ブライアン ELISA kit for metabolic phenotyping
JP4102301B2 (en) * 2001-08-21 2008-06-18 グラクソ グループ リミテッド Screening method for drug hypersensitivity reaction
US7470513B2 (en) * 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions
US20060177860A1 (en) * 2005-02-09 2006-08-10 Maria Athanasiou Genetic markers in the HLA-DQBI gene associated with an adverse hematological response to drugs
US20060183146A1 (en) * 2005-02-11 2006-08-17 Maria Athanasiou Genetic markers in the HLA-C gene associated with an adverse hematological response to drugs
CN102925567B (en) * 2012-10-23 2013-12-11 山东省皮肤病性病防治研究所 Use of HLA-B*1301 alleles

Also Published As

Publication number Publication date
KR102154816B1 (en) 2020-09-11
EP2787085A1 (en) 2014-10-08
CN102925567B (en) 2013-12-11
JP6188810B2 (en) 2017-08-30
JP2016503287A (en) 2016-02-04
US20150218634A1 (en) 2015-08-06
EP2787085A4 (en) 2015-07-22
PH12014501775A1 (en) 2014-11-10
CN102925567A (en) 2013-02-13
US9567636B2 (en) 2017-02-14
KR20150070042A (en) 2015-06-24
PH12014501775B1 (en) 2014-11-10
WO2014063433A1 (en) 2014-05-01
EP2787085B1 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
ZA201406082B (en) Use of ccr3-inhibitors
HK1203974A1 (en) Anti -transglutaminase 2 antibodies - 2
SG11201403447VA (en) Use of hla-b*1301 allele
EP2909319A4 (en) Inhibition-resistant polymerases
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
GB201214120D0 (en) Yota 070812
EP2892120A4 (en) Cable
GB201220866D0 (en) Cable restictor
PT2677615T (en) Grommet
EP2892529A4 (en) Uses of (-)-perhexiline
GB201222141D0 (en) Further addtions 2
GB2517378B (en) Cable
EP2940696A4 (en) Cable
EP2807545A4 (en) Desktop extension
TWM432495U (en) M1010701_3919
GB201220196D0 (en) Magno-rebel 1
GB201214054D0 (en) Pakaging 0
GB201208532D0 (en) SockScreen 2
GB201206581D0 (en) CityJaw 1830
GB201200834D0 (en) Vinsole 3
GB201212774D0 (en) Cable stand
GB201211499D0 (en) Cable stand
TWM432299U (en) M1010701_3919
TWM432411U (en) M1010701_3919
TWM432248U (en) M1010701_3919